NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Under IRP in the UK when DCVax-L gets marketing application approved, will Northwest Biotherapeutics then be able to get DCVax-L approved by regulators in Australia, Canada, Japan, Singapore, Switzerland and the USA, as well as the European Medicines Agency, individual EU member states and those in the EEA (European Economic Area) under IRP and witt new short Time horizons for authorisations, set at 60 to 110 days?

It is not that complicated.

IRP is a UK program. That set fast timelines in the UK for drugs approved elsewhere.

The UK does not decide what timelimes the FDA, EMA and others operate under.

Posts like this by DD exemplify why he needs AI so often.